Improvement of treatment adherence with growth hormone by easypod™ device: experience of an Italian centre

作者
Maria Cristina Maggio,Beatrice Vergara,Paolo Porcelli,Giovanni Corsello
出处
期刊:Italian Journal of Pediatrics [BioMed Central]
卷期号:44 (1): 113-113 被引量:25
标识
DOI:10.1186/s13052-018-0548-z
摘要

BACKGROUND: One of the most important vulnerabilities falling the efficacy of recombinant human growth hormone (r-hGH) treatment is low adherence especially in young patients. This study was planned to describe the correlation between r-hGH treatment efficacy and adherence in real-life setting using easypod™. METHODS: Forty patients younger than 18 years, affected by a clinical condition in which r-hGH is available and treated with r-hGH easypod™, were enrolled in a retrospective, observational, real-world data, monocentric trial. The study design provided the retrospective collection of records collected by a questionnaire proposed to the patients and their parents and compared with registered data by the new generation electronic device r-hGH easypod™. Number of injections and doses were collected and used to assess the percentage of administered GH doses to measure treatment adherence. The r-hGH treatment efficacy was evaluated comparing standard deviation score for height (SDS) between baseline and follow-up visit, according to clinical practice. RESULTS: The mean treatment adherence was 92.20% and it was inversely related to patients' age (R = - 0.358, p = 0.023), and significantly higher in the sub-group of patients with age between 10 and 13 years. Treatment adherence showed an inverse correlation with the years of therapy (R = - 0.453, p = 0.003) and with the number of r-hGH administrations (R = - 0.392, p = 0.012). However, the height increase did not reach a significant correlation with treatment adherence (R = - 0.067, p = 0.683). CONCLUSIONS: Children and adolescent patients with GH deficiency due to different clinical conditions show high adherence to r-hGH treatment tested by easypod™. Easypod™ could be used as an important device to control patients' adherence in daily treatment for chronic diseases with expensive drugs.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
隐形曼青的应助被byejack采纳,获得10
刚刚
suha完成签到,获得积分10
刚刚
hhh完成签到 ,获得积分10
刚刚
csy发布了新的文献求助10
刚刚
宁不惜完成签到,获得积分10
刚刚
nature通行证完成签到,获得积分10
1秒前
sky发布了新的文献求助10
1秒前
Daaz完成签到,获得积分10
1秒前
淄博烧烤完成签到,获得积分20
1秒前
1秒前
TT完成签到,获得积分10
1秒前
李老师完成签到,获得积分10
1秒前
孝顺的如南完成签到,获得积分20
1秒前
机灵花生完成签到,获得积分10
2秒前
Caicai发布了新的文献求助10
2秒前
认真向梦完成签到,获得积分10
2秒前
wjw完成签到,获得积分10
2秒前
2秒前
3秒前
一tiao小于完成签到,获得积分10
3秒前
Sam十九完成签到,获得积分10
3秒前
3秒前
yu完成签到 ,获得积分0
3秒前
ke完成签到,获得积分10
3秒前
goodjob32完成签到,获得积分10
4秒前
yy完成签到,获得积分10
4秒前
杜青完成签到,获得积分10
4秒前
TinLi的应助被369ninja采纳,获得10
4秒前
4秒前
隐形曼青的应助被Michael_li采纳,获得10
4秒前
轻松的元瑶完成签到,获得积分10
4秒前
文章多多完成签到,获得积分10
4秒前
神勇萧发布了新的文献求助10
5秒前
zhuan完成签到,获得积分10
5秒前
清爽老九发布了新的文献求助30
5秒前
wallyphinex完成签到,获得积分10
6秒前
pug完成签到,获得积分10
6秒前
自信的刘发布了新的文献求助10
6秒前
脑洞疼的应助被聪明戒指采纳,获得10
6秒前
在下厉飞雨完成签到 ,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180189
求助须知:如何正确求助?哪些是违规求助? 9570320
关于积分的说明 21810161
捐赠科研通 7776320
什么是DOI,文献DOI怎么找? 3433267
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479039